Anti-Inflammatory Therapeutics Market Worth Will Be US$ 130.6 Billion By 2026: Credence Research

SAN DIEGO, April 16, 2018 -- According to the latest report published by Credence Research, Inc. “Anti-inflammatory Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global anti-inflammatory therapeutics market is projected to reach US$ 130.6 Bn by 2026, expanding at a CAGR of 8.5% from 2018 to 2026.

Market Insights                                                  

Anti-inflammatory therapeutics market projected to US$ 130.6 Bn by 2026 with CAGR of 8.5% throughout the forecast period from 2018 to 2026. Biologics and immune selective anti-inflammatory derivatives (ImSAIDs) are the promising drugs classes that will play the main role in the market. Global anti-inflammatory therapeutics market from 2018-2026 study is based on exhaustive analysis with insights from industry stakeholders. The detailed study incorporates the market landscape and its growth scenarios for the forecasting period from 2018-2026.

According to World Health Organization (WHO), around 235 Mn individuals experience the ill effects of asthma around the globe. Symptomatic help amid the inflammation gives alleviation to the patients suffering from inflammatory diseases. In spite of the fact that there are numerous anti-inflammatory drugs present in the market, still, there is an essential requirement for better and novel anti-inflammatory therapeutics drugs with slighter side effects and improved efficacy.

Based on the drug types, the global anti-inflammatory therapeutics market is segmented into biologics, corticosteroids, immune selective anti-inflammatory derivatives (ImSAIDs), and non-steroidal anti-inflammatory drugs (NSAIDs); additionally, the indication studied in this report are categorized into COPD, multiple sclerosis, IBD, psoriatic arthritis, gout, and Others (Osteoarthritis, Systemic Lupus, Psoriasis). Rising prevalence of inflammatory diseases and the strong drug pipeline would additionally boost the anti-inflammatory therapeutics market.

Geographically, overall anti-inflammatory therapeutics market is projected for Europe, Middle East and Africa, Asia Pacific, Latin America, and North America. As for the revenue share, in 2017, North America drives the global market and projected that the situation will remain steady amid the forecast period. However, the dominance of North America will be evidently challenged by the Asia Pacific. There are huge chances for market penetration in countries like Mexico, India, and China to the market occupiers at present having a hold in established countries. The need for anti-inflammatory therapeutics drugs has become prominent in the Asia Pacific due to rapid development of the economy, developing healthcare facilities and immense patient base.  

Browse Full Report With TOC, Figures And Tables @ http://www.credenceresearch.com/report/anti-inflammatory-therapeutics-market

Related Reports:

Osteoarthritis Treatment Market

Listeria Monocytogenes Infections Treatment Market

Autoimmune Diseases Treatment Market

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: [email protected]

Ph: +1-800-361-8290

Connect With US:

Web:  Credence Research

Facebook @ https://www.facebook.com/CredenceResearch

Twitter @ https://twitter.com/CredenceResearc

Linkedin @ https://us.linkedin.com/company/credenceresearch

G+ @ https://plus.google.com/+Credenceresearch

Our Blog: http://www.mobilecomputingtoday.co.uk/7685/anti-inflammatory-therapeutics-market-reach-worth-130-6-2026-credence-research/